ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

CMMB Chemomab Therapeutics Ltd

0.81
0.085 (11.72%)
시간외 거래
최종 업데이트: 05:56:50
15분 지연
기업명 주식 심볼 시장 주식 타입
Chemomab Therapeutics Ltd CMMB 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.085 11.72% 0.81 05:56:50
개장가 저가 고가 종가 전일 종가
0.735 0.6921 0.85 0.81 0.725
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/05/202420:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/05/202420:00GLOBEChemomab Therapeutics Announces First Quarter 2024 Financial..
08/05/202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/05/202420:00GLOBEChemomab Therapeutics Granted 180-Day Extension by Nasdaq to..
02/05/202420:00GLOBEChemomab Therapeutics to Present at 2024 Aegis Virtual..
24/04/202420:00GLOBEChemomab Therapeutics to Report First Quarter 2024 Financial..
18/04/202420:00GLOBEChemomab Reports New Peer-Reviewed Publication Reinforcing..
02/04/202420:00GLOBEChemomab to Host Virtual Key Opinion Leader Webinar on..
25/03/202420:06GLOBEChemomab Awarded New European Patent for CM-101, Its..
07/03/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/03/202421:00PRNUSChemomab Therapeutics Announces Year End and Fourth Quarter..
05/03/202421:00PRNUSChemomab Therapeutics to Participate in Leerink Global..
20/02/202423:20APSBiotech Shares Massively Bid Up Before Opening Bell
20/02/202421:00PRNUSChemomab Awarded New Patents for CM-101, Its First-in Class..
14/02/202421:00PRNUSChemomab Therapeutics to Report Fourth Quarter and Full Year..
05/02/202421:00PRNUSChemomab Therapeutics to Participate in Upcoming Investor..
30/01/202421:00PRNUSChemomab Therapeutics Announces New Publication Reinforcing..
03/01/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/01/202421:00PRNUSChemomab Announces Completion of Patient Enrollment in..
16/11/202321:00PRNUSChemomab Presentation at ACR Convergence 2023 Provides..
16/11/202306:35EDGAR2Form SC 13D/A - General statement of acquisition of..
15/11/202321:00PRNUSChemomab Therapeutics Receives FDA Fast Track Designation..
13/11/202322:00PRNUSChemomab Presents New Clinical Data Supporting CM-101's..
09/11/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202322:00PRNUSChemomab Therapeutics Announces Third Quarter 2023 Financial..
07/11/202306:15PRNUSChemomab Therapeutics Discloses Receipt of Nasdaq Notice..
06/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
30/10/202321:33EDGAR2Form F-3/A - Registration statement by foreign private..
30/10/202320:00PRNUSChemomab Therapeutics to Report Third Quarter 2023 Financial..
26/10/202320:00PRNUSChemomab Therapeutics to Present at Upcoming Scientific..
17/10/202305:25EDGAR2Form F-3 - Registration statement by foreign private issuers
28/09/202320:00PRNUSChemomab Therapeutics to Present Its CM-101 Clinical Program..
29/08/202320:00PRNUSChemomab Therapeutics to Present at the H.C. Wainwright 25th..
14/08/202321:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/08/202321:00PRNUSChemomab Therapeutics Announces Second Quarter 2023..
08/08/202319:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/07/202306:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/07/202304:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/06/202320:00PRNUSChemomab Therapeutics Announces Publication in JCI Insight..
26/06/202320:00PRNUSChemomab Therapeutics Presents Data Reinforcing the Clinical..
21/06/202320:00PRNUSChemomab Therapeutics Reports Positive Data from Secondary..
05/06/202320:00PRNUSChemomab Therapeutics Announces Executive Leadership Changes..
02/06/202322:00PRNUSPatient Data Presented at 2023 EULAR Congress Highlights How..
24/05/202320:00PRNUSChemomab Therapeutics to Participate in Upcoming Scientific..
11/05/202319:00PRNUSChemomab Therapeutics Announces First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock